Liquent Regulatory Solutions for Life Sciences |
||
June 7, 2007 |
||
|
 |
Liquent is the global leader in providing regulatory software solutions, information products and related services for the life sciences industry. Liquent’s software and service offerings help to ensure that clients meet the strict standard of regulatory authorities across the world, helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time. In addition to technology and services, Liquent’s IDRAC database service provides the most comprehensive intelligence in the life science regulatory environment in 39 of the largest markets in the world. As a result, 48 out of the top 50 global life science companies rely on Liquent to stay current with the latest intelligence and to provide technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients’ and physicians’ timely access to new drugs. Over the last decade many thousands of regulatory submissions have been produced using Liquent’s world-class products and expert services. Headquartered in Horsham, Pennsylvania, the European headquarters resides in Chippenham, UK with additional offices in Paris, France; Munich, Germany; and Tokyo, Japan Liquent is a Thomson Scientific company, a unit of The Thomson Corporation. Thomson acquired Liquent's parent company, Information Holdings Inc., in November 2004. The Thomson Corporation (www.thomson.com), with 2004 revenues of $8.10 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Connecticut, Thomson has approximately 40,000 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC). This strong financial position enables Liquent to enjoy financial flexibility of a company many times its size. As a result, Liquent is investing millions of dollars into new product development so that we can deliver on our long term strategy to allow the life sciences industry to realize the strategic benefits of submission lifecycle management that arise as a result of the eCTD.
|
|
||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 |
